Introduction
Enzymes use their active site structures to guide chemical conversion of substrates to products through several transition states. The unique local environments of each active site enforce specific orientations and conformations of the bound substrates to promote the chemical conversion, while also stabilizing the leaving groups in the formation of products.
Enzymes that perform the same reaction usually share a highly conserved active site with sequence and structural features derived from the same evolutionary origin. However, exceptions to the rule exist, in which different active-site structures are recruited by enzymes of unrelated origins to catalyze the same chemical reaction 1 . When analogous enzymes of distinct structures are employed for the same reaction, a fundamental question is whether the difference in structures would influence the control of reaction kinetics. Of interest is the determination of the slowest step in a catalytic cycle that regulates the timing of turnover, which is associated with the highest activation energy barrier in the reaction coordinate.
The TrmD and Trm5 enzymes form an exemplary pair of analogous enzymes for the same reaction 2; 3 . These enzymes catalyze methyl transfer from the methyl donor AdoMet to the N1 position of G37 to synthesize the modified m1G37 base 3' adjacent to the tRNA anticodon.
TrmD is encoded by bacterial species and is characterized by an unusual AdoMet-binding fold that contains a rare protein subdomain known as the trefoil knot 4; 5; 6 . In contrast, Trm5 is encoded by eukaryotic and archaeal species and is characterized by the widely popular protein fold known as the Rossmann fold for binding the methyl donor 3; 7; 8; 9 . The Rossmann fold and the trefoil knot structure share no common structural or sequence motifs and represent unrelated protein families 3; 5; 7 . In addition, TrmD exists as a homodimer with the two active sites assembled at the dimer interface 4; 5 , in which both monomers make substantial and interdigitating contributions to AdoMet binding. In contrast, Trm5 exists as a monomer and is active within a monomeric structure 3; 10 . With respect to tRNA recognition, these two enzymes also adopt different strategies: while Trm5 requires the integrity of the tRNA L shape, TrmD 4 requires only a simple stem-loop structure mimicking the bottom half of the L shape 11 . Although there are other analogous pairs of tRNA modification enzymes, such as the pair consisting of the bacterial TrmJ (with a trefoil knot structure) and the eukaryotic Trm7 (with the Rossmann fold) for synthesis of 2'-O-methylation at position 32 of the anticodon loop 12 , the TrmD-Trm5 pair is by far the best characterized.
The m1G37 modified base synthesized by TrmD and Trm5 is conserved in all three domains of life and is present in both the cytoplasm and mitochondria as one of the few tRNA modifications that are essential for growth 2; 13; 14; 15; 16 . The m1G37 modification plays multiple and important roles in translation: it enhances aminoacylation by archaeal cysteinyl-and phosphoseryl-specific aminoacyl-tRNA synthetases (aaRSs) 17; 18 , it prevents mis-charging of yeast tRNA Asp by ArgRS 19 , and it accelerates entry of aminoacyl-tRNAs to the ribosome 20 , while blocking frame-shifts of tRNA-ribosome complexes during translation 15; 21 . The isolation of TrmD and Trm5 for the synthesis of m1G37 is significant, indicating the existence of separate structural pathways that arose early in evolution for the making of an essential modified base for tRNA maturation. Here, we use TrmD and Trm5 as examples of a pair of analogous enzymes to address how each controls the kinetics of the m1G37 synthesis reaction. We show that TrmD and Trm5 differ in the rate-limiting step of their catalytic cycle, and that their kinetic differences can be correlated with structural differences. Importantly, the structure-kinetic separation of TrmD from Trm5 is reminiscent of the previously observed separation between the two classes of aaRSs that catalyze aminoacyl transfer to tRNA 22 . Thus, the results of this study will have impact on enzymes that catalyze both aminoacyl transfer and methyl transfer to tRNA during the process of decoding genetic information.
Results

Separation of TrmD from
Trm5 by pre-steady-state kinetics. We used E. coli TrmD and the archaeal Methanococcus jannaschii Trm5 as a representative pair for the synthesis of m1G37. Both enzymes are well characterized by x-ray crystal structures to have distinct AdoMet-binding folds 5; 8; 9 . In addition, the crystal structure of M. jannaschii Trm5 in complex with tRNA and AdoMet has recently been solved 9 , which shows base flipping of G37 from the anticodon loop into the active-site pocket. This base flipping is a common feature of all nucleic acid modification enzymes for which crystal structures are available. In steady-state kinetics, E.
coli TrmD and M. jannaschii Trm5 have similar values of K m with respect to both the tRNA and AdoMet substrates 3 . However, the lack of differentiation in steady state does not mean that these two enzymes share a similar kinetic mechanism, because steady-state analysis does not resolve individual steps in a catalytic cycle. Indeed, a separate single-turnover analysis of M.
jannaschii Trm5 has shown that the enzyme exhibits a faster rate of methyl transfer than the steady-state rate 7 , indicating that the steady-state rate does not report on methyl transfer for this enzyme. To better explore the kinetic mechanism of TrmD and Trm5 and to gain insight into the meaning of the steady-state rate, we examined pre-steady-state kinetics for these two enzymes. Because the preference for tRNA sequences for each enzyme differs, we chose the unmodified transcript of E. coli tRNA Leu as the substrate for TrmD and that of M. jannaschii tRNA Cys for Trm5, both of which are quantitatively modified by high concentrations of enzymes, indicating that they both have a well-folded structure 3; 23 .
The pre-steady-state analysis was performed with saturating AdoMet relative to the K m of AdoMet for each enzyme. The tRNA substrate was maintained in a 10-fold molar excess of enzyme to permit one turnover of the reaction on the enzyme and subsequent steady-state synthesis. The amount of the m1G37-tRNA product synthesized was measured and calculated as the fraction (%) per active site of the enzyme. This analysis showed that while the synthesis of m1G37-tRNA by TrmD occurred in a time-dependent linear fashion, the synthesis by Trm5 occurred in a rapid burst phase followed by a slower and linear phase (Fig.1) . The observation of a k chem greater than k cat for Trm5 confirms that the steady-state k cat does not represent the event of methyl transfer, but rather a physical step after the transfer. The active fraction of Trm5 was estimated at 20% based on the amplitude of the burst (Fig.1) ; this corresponds closely to the previously reported plateau values for methyl transfer to the unmodified tRNA transcript 3 . The low levels of active fraction may be due to heterologous expression of M. jannaschii Trm5 in E.
coli.
Tight binding of Trm5 to products. The burst kinetics of Trm5 suggests that the release of reaction products is slow such that it limits the rate of enzyme turnover. This was evaluated by determining the enzyme affinity for each substrate relative to the product. A higher affinity to the product than to the substrate would support the notion of slow product release. The equilibrium constant K d of Trm5 for the tRNA substrate was determined from single turnover kinetics with increasing concentrations of the enzyme. All time courses of methyl transfer showed single exponential kinetics ( Fig.2A) , confirming the rapid binding equilibria between the enzyme, tRNA and AdoMet. Fitting the data of rate as a function of Trm5 concentration to a hyperbolic equation yielded the maximum rate of 0.12 ± 0.02 s -1 , consistent with the k chem measured from presteady-state analysis, and an apparent K d for the tRNA substrate of 0.7 ± 0.1 µM (Fig.2B ), similar to the K d reported previously 7 .
The K d of Trm5 for the m1G37-tRNA product was determined by treating the product as an inhibitor of the methyl transfer reaction. The m1G37-tRNA product was synthesized from the methyl transfer reaction and was purified away from the unreacted substrate by a previously developed method 24 . It was used to form a series of Trm5-product complexes that was assayed 7 for the m1G37 synthesis activity in pre-steady-state kinetics. While increasing concentration of the product had little effect on the rate of the burst or steady-state phase, it progressively decreased the amplitude of the burst phase (Fig.2C) , indicating that the dissociation of the product from Trm5 was slow such that it limited the availability of the enzyme for the methyl transfer reaction. A fit of the data to a quadratic equation yielded a K d of 0.2 ± 0.1 µM of the enzyme-product complex (Fig.2D) , lower than the K d (0.7 ± 0.1 µM) of the enzyme-substrate complex by 3-4-fold. This result demonstrates the tight binding affinity of Trm5 for the m1G37-tRNA product.
The methyl transfer reaction converts AdoMet to S-adenosyl homocysteine (AdoHcy). The K d constants of the enzyme for AdoMet and AdoHcy were determined to address the affinity for each. The K d for AdoMet was determined by formation of a series of Trm5-AdoMet complexes that was used to monitor the m1G37 synthesis reaction in pre-steady state. As the AdoMet concentration increased, the amplitude of the burst phase also increased (Fig.3A) , indicating the (Fig.3B) . Determination of K d for AdoHcy was determined similarly to that for the m1G37-tRNA product. A series of Trm5-AdoHcy complexes was preformed and used to inhibit the m1G37 synthesis reaction. While the increase in the concentration of AdoHcy had little effect on the burst or steady-state rate, it progressively decreased the amplitude of the burst phase (Fig.3C) . Fitting the amplitude data vs. the concentration of AdoHcy to a hyperbolic equation revealed a K d of 20 ± 5 nM (Fig.3D) , which is nearly 20-fold lower than the K d of 0.44 ± 0.09 µM for AdoMet (Fig.3B) , demonstrating the preferential tight binding of Trm5 to AdoHyc than to AdoMet. In fact, analysis of the K d values of the two products reveals that Trm5 affinity for AdoHcy is higher than that for the m1G37-tRNA product (K d = 0.2 ± 0.1 µM) by 20-fold, indicating a specific role of AdoHcy in product release.
Kinetics of TrmD and stoichiometry of product formation. The lack of burst kinetics of TrmD suggests that the steady-state turnover rate k cat is not limited by product release. To better understand the meaning of k cat , the rate of methyl transfer was measured from single turnover kinetics. All time courses of m1G37 synthesis showed single exponential kinetics (Fig.4A) , indicating that the formation of TrmD-tRNA-AdoMet complexes was in rapid equilibrium binding and that the kinetics of the reaction was not limited by binding but by the rate of methyl transfer. Table 1 .
Because TrmD functions as a dimer, the stoichiometry of m1G37 synthesis is of interest.
This was determined by measuring the amount of m1G37 synthesis per TrmD dimer at the time point that allowed one turnover (11 sec). A saturating concentration of tRNA relative to the K d For measurement of tRNA binding, quenching of intrinsic tryptophan fluorescence was also observed and the data was similarly recorded as in the case of AdoMet, except that the magnitude of each emission peak (at 330 nm) was corrected for dilution and for inner filter effect, due to absorption of tRNA at the excitation and emission wavelengths. Fitting the fluorescence quenching data to a quadratic equation yielded a K d of 0.30 ± 0.03 µM for tRNA (Fig.6C) , similar to the value obtained by kinetics (Fig.4B) . The stoichiometry of tRNA binding was then determined by using a high concentration of TrmD relative to the K d (tRNA) to drive the binding interaction. Analysis of fluorescence data as a function of the molar ratio of tRNA to the dimer also revealed a biphasic quenching curve (Fig.6D) . The initial quenching was steep and linear with respect to the molar ratio up to the value of 1, which was followed by a much flatter second phase. These data indicate that each TrmD dimer can specifically bind only one tRNA, and that the further fluorescence quenching at higher tRNA concentrations is probably due to non-specific binding interactions. The stoichiometry of one tRNA binding per dimer is consistent with the stoichiometry of methyl transfer. Thus, while the two subunits of TrmD can both simultaneously bind AdoMet, only one can bind tRNA at a time to perform the methyl transfer reaction. Trm5 as an exemplary pair, we examined their control of the catalytic cycle by pre-steady-state kinetics and applied the rate constant k chem to encompass all of the steps required for product synthesis and the constant k cat for those involved in product release. For the m1G37 synthesis reaction, k chem includes the terms for substrate binding, active site rearrangement, base flipping of G37, deprotonation of N1 of G37, and methyl transfer to N1 from AdoMet, whereas k cat also includes the terms for breakdown of the ternary complex with m1G37-tRNA and AdoHcy and the release of products from the enzyme. Here we show that Trm5 exhibits burst kinetics and that it has preferential binding affinities to the reaction products relative to the respective substrates, indicates that this enzyme uses the rate-limiting product release step to control its catalytic cycle. In contrast, we show that TrmD lacks the burst kinetics and that it exhibits identical rates for the synthesis and release of products, indicating that this enzyme uses the rate-limiting product synthesis to control its catalytic cycle. Thus, the two enzymes exert different kinetic controls of their catalytic cycle.
The distinction between TrmD and Trm5 is reminiscent of the distinction between the two classes of aaRSs in both structure and kinetics. The family of aaRSs includes the 20 canonical enzymes, each of which uses the energy of ATP hydrolysis to activate an amino acid substrate and to transfer the activated aminoacyl-adenylate to the 3' end of cognate tRNAs to synthesize aminoacyl-tRNAs as substrates for protein synthesis 25 . Class I aaRSs bind ATP in the Rossmann fold, whereas class II aaRSs bind ATP in a non-Rossmann fold created by the interface of oligomeric subunits (typically homodimers). Such class-specific structural features of aaRSs are recognizable in ways that separate TrmD from Trm5 and are directly relevant to the spatial binding of ATP or AdoMet, which share in common an adenosine moiety that is likely to provide fundamental constraints in the rate of chemical conversion and the rate of catalytic turnover. Indeed, structural analysis of these enzymes has consistently shown that enzymes of the same active-site structure bind AdoMet (Fig.7A,B) or ATP (Fig.7C,D) in a similar conformation. Specifically, the Rossmann fold in methyl transferases binds AdoMet in an extended conformation with a degree of 160-180 o for the C4'-C5'-Sδ-Cγ dihedral angle ( Fig.7A) 8; 9 , similar to the extended conformation of ATP in the Rossmann fold of aaRSs (Fig.7C) 
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. In contrast, the non-Rossmann fold in methyl transferases binds AdoMet in a bent conformation with an ~80 o degree of the dihedral angle mentioned above (Fig.7B) , similar to the bent conformation of ATP in the non-Rossmann fold of aaRSs (Fig.7D) 
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. In parallel, kinetic analysis has consistently shown that enzymes of the Rossmann-fold active site exhibit burst kinetics, such as class I aaRSs 22 , while enzymes of the non-Rossmann fold active site assembled at the interface of oligomeric subunits lack burst kinetics, such as class II aaRSs . SepRS exhibits burst kinetics 18 , indicating an exception to the no-burst rule of non-Rossmann enzymes, but the basis for the exception is not known, because there is no structural data showing the geometry of the ATP bound in the active site 35; 36 . Thus, it is important to recognize that, while further data are needed to address possible exceptions, the proposed model serves as a useful foundation to relate how each structure confers the specific kinetic property.
Product release from Trm5. Burst kinetics has been used as a tool to measure the affinities of Trm5 to AdoMet and tRNA, and to the respective products of these substrates. The advantage of this method is that the binding of substrates to Trm5 was fast and under the diffusion control so that the reaction kinetics could be used to monitor the extent of binding.
Another advantage is that affinities were measured in the catalytically competent state of Trm5 during the reaction of methyl transfer. The observation that Trm5 binds with a 3-4 fold higher affinity to m1G37-tRNA relative to tRNA, and with a ~20-fold higher affinity to AdoHcy relative to AdoMet, is consistent with the existence of a highly stable ternary product complex of the enzyme with m1G37-tRNA and AdoHcy, which is slow to release the products. Of significance is the particularly tight binding of Trm5 to AdoHcy (K d = 20 nM), indicating that the release of this product is the dominant factor in the overall catalytic turnover. A similar case is found in the related DNA methyl transferase M.HhaI (responsible for synthesis of m5C in DNA), where the release of AdoHcy is the slowest in the catalytic cycle and it occurs before the release of the methylated DNA product 37; 38 , indicating that as soon as AdoHcy is released, the release of the nucleic acid product quickly follows. This order of release is likely to apply to Trm5 as well. 14 A possible rationale for the dominance of AdoHcy in the Trm5 turnover is discernable by biochemical and structural analysis of the enzyme. The recent ternary complex of Trm5 with AdoMet and tRNA reveals that the methyl donor is tightly bound in the active site (Fig.7A (Table 1) indicates that the methyl transfer event on the enzyme is slow relative to product release such that k chem dominates k cat . A key feature of the methyl transfer by TrmD is the half-of-the-sites reactivity, where although both active sites of the homodimeric enzyme are capable of binding AdoMet, only one binds tRNA and only one catalyzes methyl transfer (Fig.6) .
The origin of the half-of-the-sites reactivity is not known at present, due to the lack of tRNAbound crystal structure. Note that while the two active sites of TrmD are identical upon AdoMet or AdoHcy binding in binary crystal structures of TrmD 4; 5 , this symmetry may result from crystal packing forces and does not exclude the possibility of a pre-existing asymmetry prior to tRNA binding. Alternatively, the half-of-the-sites reactivity may arise during tRNA binding to a preexisting symmetric dimer to the highly interdigitating and expansive interface of the two monomers (accounting for 26% of the total surface per monomer), which may form the binding surface for the G37 base and may be constructed in such a way to allow only one tRNA to bind to one subunit or alternatively bind across the dimer interface, leading to the stoichiometry of one tRNA bound per dimer. Half-of-the-sites activity has been previously shown for dimeric and tetrameric aaRSs of both the Rossmann-fold and the non-Rossmann-fold type 17; 28; 29; 43; 44; 45 .
The discovery of half-of-the-sites reactivity for TrmD suggests that this phenomenon may be general to multimeric enzymes that operate on tRNA.
The structural basis for the tRNA-induced asymmetry of TrmD cannot be resolved by the present data and further experiments are necessary. One possibility of the asymmetry is an oscillating model, in which the two active sites are both active and the one with the bound G37 of tRNA catalyzes methyl transfer and the synthesis of m1G37-tRNA on the subunit activates the second subunit to bind to a new G37 in a different tRNA, which then triggers the release of the m1G37-tRNA product from the first subunit. The K d values determined from fluorescence titration are consistent with some aspects of this oscillating model, showing that a TrmD dimer binds the m1G37-tRNA product with a ~10-fold higher affinity (K d = 40 ± 2 nM) relative to the affinity for the tRNA substrate (K d = 0.3 ± 0.03 µM) (Fig.6C, F) . Because the catalytic cycle of TrmD is not limited by product release, the tight binding of the m1G37-tRNA product on one subunit can serve to activate the second subunit to bind to a new tRNA substrate. Note that because the fluorescence analysis presented here was performed with just the enzyme-product or enzyme-substrate complexes, it cannot be used to determine the enzyme-product affinity upon binding of a second molecule of substrate. New fluorescence tools are being developed to address the dynamics of the two subunits in the oscillating model. Other possibilities of the asymmetry of TrmD also exist. For example, a variation of the oscillating model is that the one subunit with the bound G37 of tRNA does not catalyze methyl transfer but moves the nucleic acid substrate to the second active site to perform methyl transfer. Alternatively, the two active sites can be unequal upon tRNA binding and only one of the two is active for methyl transfer.
Implications for biology. This study demonstrates that the analogous enzymes TrmD and
Trm5 control their catalytic cycle by distinct kinetic steps that are directly related to their unique active-site structures. While TrmD controls its catalytic cycle by the rate of methyl transfer, Trm5 controls the cycle by coordinating the release of AdoHcy. The specific control may serve a useful biological function for each enzyme. For example, the half-of-the-sites reactivity of TrmD can be considered an extreme case of negative cooperativity, as has been suggested for dimeric aaRSs that exhibit this property 46 . The half-of-the-sites reactivity of TrmD occurs at the tRNA binding step, suggesting that the negative cooperativity between the two subunits with respect to tRNA binding would confer the enzyme a high sensitivity to intracellular changes of tRNA concentrations, such as those occurring in stress conditions that can drastically curtail biosynthesis of tRNA 47 . Because TrmD is proposed to act early in the pathway of tRNA maturation (due to its ability to synthesize m1G37 without complete folding of tRNA) 9 , this innate sensitivity to reduced tRNA levels in stress conditions can help to establish an early decision point to arrest the m1G37 synthesis and to terminate the maturation pathway so as to eliminate the cellular expenditure for further modification reactions. Conversely, the kinetic 17 control of Trm5 in product release is relevant to the utility of the m1G37-tRNA product as the obligate precursor for synthesis of the complex wybutosine base in tRNA Phe at the 37 position 48 .
The slow product release by Trm5 may be a strategy to protect the m1G37-tRNA product and to channel it to the downstream enzyme in the wybutosine biosynthesis pathway. Similar models for the channeling are the two-step reaction pathways that synthesize certain aminoacyl-tRNAs by the action of two enzymes 18; 49 , where the aaRS for the first reaction delays product release and facilitate product transfer to the second enzyme in order to promote rapid production of the end product. Importantly, the wybutosine modification in tRNA 
, where k chem is the rate constant for the chemistry step, and Active site titration and stoichiometry of methyl transfer. Enzyme (100 nM) in one syringe was rapidly mixed with tRNA (10-300 nM) and AdoMet (30 µM, specific activity 1990 dpm/pmol) in the second syringe in a total volume of 20 µL to initiate methyl transfer. An aliquot of the reaction (15 µL) was quenched by acid after the time period that allowed for one cycle of methyl transfer (11 sec) and was analyzed by a scintillation counter to determine the amount of m1G37-tRNA synthesis. The data were fit to the following equation to derive the active fraction:
, where y represents the methylated tRNA product after one turnover; Eo is the active enzyme concentration; S is the tRNA concentration; K d is the dissociation constant for tRNA 22; 50 .
The stoichiometry of methyl transfer was determined by rapid mixing of active enzyme dimer 51 . All structures show the conserved residues that stabilize the specific conformation of the cofactor, which exhibits an extended conformation in (A) and (C) and in a U-shaped conformation in (B) and (D). 
